Wockhardt Share Price
Wockhardt Ltd.
Performance of Wockhardt Shares 
Open Price
Prev. Close
Volume
Value
About Wockhardt
Wockhardt is a multinational pharmaceutical and biotechnology company that offers low-cost, high-quality medications to promote global health. It is the top research-based global healthcare company in India, with relevance in the pharmaceutical and biotechnology industries as well as a network of cutting-edge Super Speciality Hospitals.
With 8600 Wockhardt Associates representing 21 different nationalities worldwide, Wockhardt is a truly Indian multinational corporation. Its businesses include the production and sale of pharmaceutical and biopharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines. It has 12 manufacturing facilities and 3 research centers.
Wockhardt, which has its headquarters in Mumbai, India, also operates fully in the United States, the United Kingdom, Ireland, and France. Additionally, it markets in developing nations like Russia, Brazil, Mexico, Vietnam, the Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon, and Kuwait.
Wockhardt has extensive experience manufacturing medications, biopharmaceutical formulations, and active pharmaceutical ingredients (API) on a global scale.
To manufacture all different dosage forms, including sterile injectables and lyophilized goods, the company has effectively developed an integrated multi-technology capacity. 12 manufacturing facilities in India, the US, and Europe are run by highly qualified technicians and are in compliance with the US FDA, UK MHRA, and EMEA.
Six specialized manufacturing facilities for both recombinant formulations and bulk biopharmaceuticals are available at the state-of-the-art biotech facility in Aurangabad. The Wockhardt Biotech Park has established a new standard for the production of recombinant goods using cutting-edge technologies.
Through its diverse medical and social programs and projects, Wockhardt's CSR arm, the Wockhardt Foundation, has in a short time touched 3 million people. The Foundation is an organization that promotes social awareness, social development, and human values.
Do you want to know more about the Wockhardt Share Price? Click Here now to know the price of the Wockhardt Shares today.
With 8600 Wockhardt Associates representing 21 different nationalities worldwide, Wockhardt is a truly Indian multinational corporation. Its businesses include the production and sale of pharmaceutical and biopharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines. It has 12 manufacturing facilities and 3 research centers.
Wockhardt, which has its headquarters in Mumbai, India, also operates fully in the United States, the United Kingdom, Ireland, and France. Additionally, it markets in developing nations like Russia, Brazil, Mexico, Vietnam, the Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon, and Kuwait.
Wockhardt has extensive experience manufacturing medications, biopharmaceutical formulations, and active pharmaceutical ingredients (API) on a global scale.
To manufacture all different dosage forms, including sterile injectables and lyophilized goods, the company has effectively developed an integrated multi-technology capacity. 12 manufacturing facilities in India, the US, and Europe are run by highly qualified technicians and are in compliance with the US FDA, UK MHRA, and EMEA.
Six specialized manufacturing facilities for both recombinant formulations and bulk biopharmaceuticals are available at the state-of-the-art biotech facility in Aurangabad. The Wockhardt Biotech Park has established a new standard for the production of recombinant goods using cutting-edge technologies.
Through its diverse medical and social programs and projects, Wockhardt's CSR arm, the Wockhardt Foundation, has in a short time touched 3 million people. The Foundation is an organization that promotes social awareness, social development, and human values.
Do you want to know more about the Wockhardt Share Price? Click Here now to know the price of the Wockhardt Shares today.
Fundamentals of Wockhardt Shares
Market Cap |
P/E Ratio |
P/B Ratio |
Industry P/E |
|---|---|---|---|
Rs. 2218.24 Cr |
18.80 |
6.05 |
62.88 |
ROE |
EPS (TTM) |
Dividend Yield |
Book Value |
|---|---|---|---|
33.51 % |
-9.72 |
1.12 % |
142.07 |
Similar Stocks
FAQ’s
How to buy Wockhardt Ltd. shares?
All you have to do to buy Wockhardt Ltd. share is download Nuuu app, create a demat account, and get your KYC documents verified online.
Can I buy Wockhardt Ltd. shares?
Yes you can buy Wockhardt Ltd. shares, all you need is to have a verified demat account with Nuuu. And enjoy benefits like free brokerage credits and more.
What is the Market Cap of Wockhardt Ltd. shares?
As of 01 Apr`23 the Market Cap of Wockhardt Ltd. is 2218.24.
What is the PE and PB ratio of Wockhardt Ltd. stock?
As of 01 Apr`23 the PE is 18.80 and PB is 6.05.
Board Meeting
Publish Date: 13/02/2023
Quarterly Results
Board Meeting
Publish Date: 12/08/2022
Quarterly Results
Board Meeting
Publish Date: 30/05/2022
Audited Results
Rights Announcement
Publish Date: 08/03/2022
Rights Issue
Ex Rights
Publish Date: 08/03/2022
inter alia, In furtherance to the intimation made on 3 rd January, 2022 by the Company,a meeting of the board of directors of the Company (? Board?) was held on Thursday, 6th January, 2022 whereby the Board has, inter alia, considered and approved, subject to receipt of relevant approvals, if and as may be required, issue of equity shares by way of a rights issue to the existing shareholders of the Company for an amount not exceeding Rs.1,000 crore (Rupees One Thousand Crores only) in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, the Companies Act, 2013 and other applicable laws (?Issue?). The objective of the Issue is to, inter alia , meet the Company?s financing needs for repayment of subordinated debt due, financing research and development initiatives, general corporate purposes and/ or such other use of process as may be permitted under the applicable laws The Board also authorised the Capital Raising Committee of the Board to decide on the terms and conditions of the Issue including the rights entitlement ratio, the issue price, record date, timing of the Issue and other related matters.
Board Meeting
Publish Date: 03/03/2022
Rights Issue
Board Meeting
Publish Date: 27/01/2022
Quarterly Results
Board Meeting
Publish Date: 06/01/2022
Inter alia, for considering and approving various fund raising options for the Company, as the Board may deem appropriate
Board Meeting
Publish Date: 08/11/2021
Quarterly Results
Board Meeting
Publish Date: 22/07/2021
Quarterly Results
Board Meeting
Publish Date: 27/05/2021
Audited Results Inter alia, to discuss: raising of funds by issue of Equity Shares, Global Depository Receipts, American depository receipts, Foreign Currency Convertible Bonds, fully convertible debentures, partly convertible debentures, preference shares convertible into Equity Shares, and/or any other financial instruments convertible into Equity Shares (including warrants, or otherwise, in registered or bearer form) and / or any security convertible into equity Shares, combination of any of the aforementioned securities by way of one or more public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to consent of shareholder at the ensuing Annual General Meeting and such approvals as may be required, and to approve ancillary actions for the above mentioned fund raising
Board Meeting
Publish Date: 21/05/2021
Inter alia, to consider and approve Meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on 21st May, 2021, inter-alia, to consider and approve the proposal for raising of funds through issuance of Non-convertible Debentures on private placement basis.
Open A Free Demat Account
Sign Up
